Pages that link to "Raynaud's phenomenon"

The following pages link to Raynaud's phenomenon:

Displayed 50 items.

• Necrolytic migratory erythema ‎ (← links)
• Nephritic syndrome ‎ (← links)
• Brimonidine (ophthalmic) ‎ (← links)
• Dexketoprofen ‎ (← links)
• Cherry angioma ‎ (← links)
• Blanch (medical) ‎ (← links)
• Vascular disease ‎ (← links)
• Raynaud phenomenon (redirect page) ‎ (← links)
  • Double stranded DNA antibody ‎ (← links)
  • Vasculitis ‎ (← links)
  • Arthritis ‎ (← links)
  • Prazosin ‎ (← links)
  • Hypereosinophilic syndrome ‎ (← links)
  • Polyarthritis ‎ (← links)
  • Raynaud's disease ‎ (← links)
  • Coxsackie virus ‎ (← links)
  • Relapsing polychondritis ‎ (← links)
  • Anonychia ‎ (← links)
  • Raynaud's disease (patient information) ‎ (← links)
  • Buerger's disease (patient information) ‎ (← links)
  • Systemic lupus erythematosus medical therapy ‎ (← links)
  • Amyloidosis physical examination ‎ (← links)
  • Fabry's disease physical examination ‎ (← links)
  • Systemic lupus erythematosus MRI ‎ (← links)
  • Buerger's disease overview ‎ (← links)
  • Buerger's disease differential diagnosis ‎ (← links)
  • Scleroderma pathophysiology ‎ (← links)
  • Constipation differential diagnosis ‎ (← links)
  • Waldenström's macroglobulinemia history and symptoms ‎ (← links)
  • Waldenström's macroglobulinemia physical examination ‎ (← links)
  • Goodpasture syndrome differential diagnosis ‎ (← links)
  • Lupus nephritis echocardiography or ultrasound ‎ (← links)
  • Lupus nephritis MRI ‎ (← links)
  • Dermatomyositis causes ‎ (← links)
  • Sjögren's syndrome history and symptoms ‎ (← links)
  • Pulmonary hypertension resident survival guide ‎ (← links)
  • Sandbox Lopressor ‎ (← links)
  • Sandbox Toprol XL ‎ (← links)
  • Lopressor injection/adverse reactions ‎ (← links)
  • Differentiating Churg-Strauss syndrome from other diseases ‎ (← links)
  • Differentiating cryoglobulinemia from other diseases ‎ (← links)
  • Differentiating vasculitis from other diseases ‎ (← links)
  • Differentiating Henoch-Schönlein purpura from other diseases ‎ (← links)
  • Microscopic polyangiitis differential diagnosis ‎ (← links)
  • Systemic lupus erythematosus ultrasound or echocardiography ‎ (← links)
  • SLE resident survival guide ‎ (← links)
  • Small-sized vessel vasculitis ‎ (← links)
  • Small-sized vessel vasculitis with headache ‎ (← links)
  • Small-sized vessel vasculitis with fever ‎ (← links)
  • Small-sized vessel vasculitis with fever and headache ‎ (← links)
  • Polyarthritis with weight loss ‎ (← links)
  • Psoriatic arthritis differential diagnosis ‎ (← links)
  • Lymphoplasmacytic lymphoma history and symptoms ‎ (← links)
  • Lymphoplasmacytic lymphoma physical examination ‎ (← links)
  • Primary amyloidosis physical examination ‎ (← links)
  • Familial amyloidosis physical examination ‎ (← links)
• Raynaud's phenomenon - Treatment (redirect page) ‎ (← links)
• Raynaud's syndrome (redirect page) ‎ (← links)
  • Skin changes ‎ (← links)
  • Leg ulcer ‎ (← links)
  • Syringomyelia ‎ (← links)
  • Almotriptan ‎ (← links)
  • Eletriptan ‎ (← links)
  • Arterial blood gas ‎ (← links)
  • Vascular surgery ‎ (← links)
  • Beta blockers ‎ (← links)
  • Captopril ‎ (← links)
  • Captopril and Hydrochlorothiazide ‎ (← links)
  • Rizatriptan ‎ (← links)
  • Moxonidine ‎ (← links)
  • Raynaud's disease ‎ (← links)
  • Arsenic poisoning ‎ (← links)
  • List of ICD-9 codes 390-459: Diseases of the circulatory system ‎ (← links)
  • ICD-10 Chapter IX: Diseases of the circulatory system ‎ (← links)
  • Tolperisone ‎ (← links)
  • IMITREX injection warnings and precautions ‎ (← links)
  • Almotriptan warnings and precautions ‎ (← links)
• The Living Guidelines: Chronic Stable Angina Pectoris ACE Inhibitors Therapy Polling Results for CLASS I Guidelines ‎ (← links)
• The Living Guidelines: Chronic Stable Angina Pectoris Anti lipid Therapy Polling Results for CLASS IIa Guidelines ‎ (← links)
• The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Aspirin Polling Results for CLASS I Guidelines ‎ (← links)
• The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Aspirin Polling Results for CLASS IIa Guidelines ‎ (← links)
• The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Clopidogrel Polling Results for CLASS I Guidelines ‎ (← links)
• The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Clopidogrel Polling Results for CLASS IIa Guidelines ‎ (← links)
• The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Warfarin Polling Results for CLASS I Guidelines ‎ (← links)
• The Living Guidelines: STEMI Recommendations for Beta Blocker Therapy Polling Results for CLASS III Guidelines ‎ (← links)
• The Living Guidelines: STEMI Recommendations for Beta Blocker Therapy Polling Results for CLASS I Guidelines ‎ (← links)
• The Living Guidelines: STEMI Recommendations for Beta Blocker Therapy Polling Results for CLASS IIa Guidelines ‎ (← links)
• The Living Guidelines: STEMI Reperfusion Polling Results for CLASS I Guidelines ‎ (← links)
• The Living Guidelines: STEMI Facilitated PCI Polling Results for CLASS IIb Guidelines ‎ (← links)
• The Living Guidelines: STEMI Facilitated PCI Polling Results for CLASS III Guidelines ‎ (← links)
• The Living Guidelines: STEMI Thienopyridines Polling Results for CLASS I Guidelines ‎ (← links)
• The Living Guidelines: STEMI Thienopyridines Polling Results for CLASS IIa Guidelines ‎ (← links)
• The Living Guidelines: STEMI Immediate (or Emergency) Invasive Strategy and Rescue PCI Polling Results for CLASS I Guidelines ‎ (← links)
• The Living Guidelines: STEMI Immediate (or Emergency) Invasive Strategy and Rescue PCI Polling Results for CLASS IIb Guidelines ‎ (← links)
• The Living Guidelines: STEMI Immediate (or Emergency) Invasive Strategy and Rescue PCI Polling Results for CLASS III Guidelines ‎ (← links)
• The Living Guidelines: STEMI PCI after Successful Fibrinolysis or for Patients not Undergoing Primary Reperfusion Polling Results for CLASS IIb Guidelines ‎ (← links)
• The Living Guidelines: STEMI PCI after Successful Fibrinolysis or for Patients not Undergoing Primary Reperfusion Polling Results for CLASS III Guidelines ‎ (← links)
• The Living Guidelines: STEMI Anticoagulants as Ancillary Therapy Polling Results for CLASS I Guidelines ‎ (← links)
• The Living Guidelines: STEMI Anticoagulants for STEMI patients who do not go reperfusion therapy Polling Results for CLASS IIa Guidelines ‎ (← links)
• The Living Guidelines: STEMI Anticoagulants for STEMI patients who do not go reperfusion therapy Polling Results for CLASS III Guidelines ‎ (← links)
• The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Aspirin Suggest Revisions to the CLASS I Guidelines ‎ (← links)
• The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Aspirin Suggest Revisions to the CLASS IIa Guidelines ‎ (← links)
• The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Clopidogrel Suggest Revisions to the CLASS I Guidelines ‎ (← links)
• The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Clopidogrel Suggest Revisions to the CLASS IIa Guidelines ‎ (← links)
• The Living Guidelines: STEMI Antiplatelet Agents / Anticoagulants Therapy: Warfarin Suggest Revisions to the CLASS I Guidelines ‎ (← links)
• The Living Guidelines: STEMI Recommendations for Beta Blocker Therapy Suggest Revisions to the CLASS I Guidelines ‎ (← links)
• The Living Guidelines: STEMI Recommendations for Beta Blocker Therapy Suggest Revisions to the CLASS IIa Guidelines ‎ (← links)
• The Living Guidelines: STEMI Recommendations for Beta Blocker Therapy Suggest Revisions to the CLASS III Guidelines ‎ (← links)
• The Living Guidelines: STEMI Recommendations for ACE Inhibitors Therapy Suggest Revisions to the CLASS I Guidelines ‎ (← links)
• The Living Guidelines: STEMI Recommendations for ACE Inhibitors Therapy Polling Results for CLASS I Guidelines ‎ (← links)
• The Living Guidelines: STEMI Recommendations for ACE Inhibitors Therapy Suggest Revisions to the CLASS IIa Guidelines ‎ (← links)
• The Living Guidelines: STEMI Recommendations for ACE Inhibitors Therapy Polling Results for CLASS IIa Guidelines ‎ (← links)
• The Living Guidelines: STEMI Recommendations for Angiotensin Receptor Blockers Therapy Suggest Revisions to the CLASS I Guidelines ‎ (← links)
• The Living Guidelines: STEMI Recommendations for Angiotensin Receptor Blockers Therapy Polling Results for CLASS I Guidelines ‎ (← links)
• The Living Guidelines: STEMI Recommendations for Angiotensin Receptor Blockers Therapy Suggest Revisions to the CLASS IIb Guidelines ‎ (← links)
• The Living Guidelines: STEMI Recommendations for Angiotensin Receptor Blockers Therapy Polling Results for CLASS IIb Guidelines ‎ (← links)
• The Living Guidelines: STEMI Recommendations for Aldosterone Blockers Therapy Polling Results for CLASS I Guidelines ‎ (← links)